Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

IMS and Foundation Medicine partner to advance precision medicines for cancer

IMS Health Holdings, Inc., a provider of healthcare information services, and Foundation Medicine, Inc., a provider of genomic analysis diagnostics, have collaborated to advance the understanding and effectiveness of precision medicines for treating cancer.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Lonza and Octane to evaluate Octane Cocoon cell production platform

Lonza Group Ltd. and Octane Biotech Inc. have agreed to enter into an exclusive technology evaluation of the Octane Cocoon cell production platform for personalized cell therapy manufacturing.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Biogen and Sobi's MAA for hemophilia B drug receives EMA acceptance

Biogen Inc., a biotechnology company, and Swedish Orphan Biovitrum AB, or Sobi, have received acceptance from the European Medicines Agency, or EMA, for the marketing authorization application, or MAA, of ALPROLIX, a recombinant factor IX Fc fusion protein product candidate, for the treatment of hemophilia B.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Medtronic announces management changes

Medtronic plc, a medical technology company, has named Geoff Martha as executive vice president and president of Restorative Therapies Group, or RTG.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Medtronic receives FDA approval for MRI single-chamber pacemaker

Medtronic plc, a medical technology company, has received FDA approval for the Advisa SR MRI SureScan single-chamber pacemaker with the 5076 MRI lead.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Thermo Fisher Scientific opens manufacturing site in Scotland

Thermo Fisher Scientific Inc. has expanded its campus in Inchinnan, Scotland, with the addition of a facility that will manufacture a novel and proprietary dry media powder known as Gibco Advanced Granulation Technology, or AGT.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Epizyme announces positive data from Phase I B-cell NHL and solid tumor trial

Epizyme, Inc., a clinical stage biopharmaceutical company, has announced positive data from the ongoing Phase I trial of tazemetostat, a first-in-class EZH2 inhibitor, when used as an oral monotherapy in patients with advanced B-cell non-Hodgkin lymphomas, or NHL, and solid tumors.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Cantargia licenses BioWa's POTELLIGENT technology platform

Cantargia AB, a biotechnology company, has received non-exclusive license for the POTELLIGENT technology platform from BioWa Inc., a wholly owned subsidiary of Kyowa Hakko Kirin Co., Ltd., for the production of Cantargia's proprietary product candidate, CAN04.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Peregrine receives new patent for cancer drug from European Patent Office

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, has received a new patent from the European Patent Office, or EPO, titled, Selected Antibodies Binding to Aminophospholipids and their Use in Treatment, Such as Cancer.

Published By MarketLine
02 Jul 2015
NewsWire
NewsWire

Bayer receives MHLW approval for treatment of retinal vein occlusion

Bayer HealthCare has received approval from the Ministry of Health, Labour and Welfare, or MHLW, in Japan for EYLEA, or aflibercept solution for injection, for the treatment of patients with macular edema secondary to retinal vein occlusion, or RVO.

Published By MarketLine
02 Jul 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.